Skip to content
OpenCapital
Get started

abrdn Income Credit Strategies ACP Pharma — Inventory Net

Other segment segments

Energy
$553M-5.5%
Automotive
$163M-8.4%
Food Packaging
$99M-14.7%
Home Fashion
$90M-6.3%

Other financials

Income statement

See full
Revenue$2.2B+18.2%
Net income-$459.0M-8.8%
EPS (diluted)-$0.71+10.1%

Balance sheet

See full
Cash & equivalents$1.3B-40.5%
Total debt$6.9B-5.9%
Total assets$12.9B-16.5%

Cash flow

See full
Operating cash flow$397.0M+318%
CapEx$114.0M+29.5%
Free cash flow$283.0M+205%

Valuation

See full
Market cap$0+1.6%

Profitability

See full
Gross margin-56.5%—
Net margin-3.4%-1.3pp
FCF margin20%—

Returns & leverage

See full
Return on equity-0.1%—
Debt / equity0.7×—

Where this comes from

Reported directly by abrdn Income Credit Strategies in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: abrdn Income Credit Strategies’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about abrdn Income Credit Strategies's pharma — inventory net.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is abrdn Income Credit Strategies's pharma — inventory net?
abrdn Income Credit Strategies (ACP) reported pharma — inventory net of $22M in Q1 2026.
How has abrdn Income Credit Strategies's pharma — inventory net changed year-over-year?
abrdn Income Credit Strategies's pharma — inventory net decreased by 12.0% year-over-year, from $25M to $22M.
What is the long-term trend for abrdn Income Credit Strategies's pharma — inventory net?
Over 4 years (2021 to 2025), abrdn Income Credit Strategies's pharma — inventory net has grown at a 17.7% compound annual growth rate (CAGR), from $50M to $96M.
What does pharma — inventory net mean?
Represents the total value of raw materials, work-in-progress, and finished pharmaceutical products held by the segment. This metric is vital for assessing supply chain efficiency and the segment's ability to meet market demand without overstocking. Effective inventory management is crucial for maintaining margins and avoiding obsolescence in the pharmaceutical sector.